331920 — Celemics Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Celemics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4,713	-5,238	-4,797	-3,876	12,266
Depreciation
Amortisation
Non-Cash Items	-376	-52.7	-677	-1,948	-14,533
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-189	1,255	431	434	1,095
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-4,553	-3,201	-4,150	-4,534	-380
Capital Expenditures	-422	-574	-551	-219	-117
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-21,322	2,013	1,445	5,494	2,157
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-21,744	1,439	894	5,275	2,040
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	28,053	-109	-476	-407	-368
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,745	-1,869	-3,726	333	1,375